Showing results (121-130 of 1,271) with videos related to
Sort By:
Pageof 128
Psychopharmacology Bulletin|October 21, 2003
Paroxetine treatment of depression in late lifeCharles F ReynoldsPsychopharmacology Bulletin|October 21, 2003
Magnetic resonance spectroscopy for studies of neurotransmission in vivoGraeme F MasonPsychopharmacology Bulletin|November 19, 2003
Pharmacokinetics, drug interactions, and tolerability of valproateC Lindsay DeVanePsychopharmacology Bulletin|November 11, 2003
IFN-induced depression: a role for NSAIDsGregory M Asnis, Richard De La Garza, Shari R Kohn, et al.Psychopharmacology Bulletin|January 1, 1992
The effect of paroxetine on anxiety and agitation associated with depressionD Sheehan, G C Dunbar, D L FuellPsychopharmacology Bulletin|January 1, 1992
Non-neuroleptic treatment of behavioral symptoms and agitation in Alzheimer's disease and other dementiaL S Schneider, P B SobinPsychopharmacology Bulletin|January 1, 1992
Cognitive-behavioral therapy for benzodiazepine discontinuation in panic disorder patientsM W Otto, M H Pollack, S Meltzer-Brody, et al.Psychopharmacology Bulletin|October 17, 2003
Psychotropic drug-induced weight gain alleviated with orlistat: a case seriesThomas L Schwartz, Mark BealePsychopharmacology Bulletin|October 17, 2003
An intent-to-treat method for enhancing analysis of clinical trials with rescue medication: a mixed-model approachPatricia R Houck, Sati Mazumdar, Benoit H Mulsant, et al.Psychopharmacology Bulletin|October 17, 2003
Smoking abstinence impairs time estimation accuracy in cigarette smokersLaura Cousino Klein, Elizabeth J Corwin, Michele M StinePageof 128